BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fabre JAS, Giustinniani J, Garbar C, Merrouche Y, Antonicelli F, Bensussan A. The Interleukin-17 Family of Cytokines in Breast Cancer. Int J Mol Sci 2018;19:E3880. [PMID: 30518157 DOI: 10.3390/ijms19123880] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 5.5] [Reference Citation Analysis]
Number Citing Articles
1 Song X, Wei C, Li X. The potential role and status of IL-17 family cytokines in breast cancer. Int Immunopharmacol 2021;95:107544. [PMID: 33740640 DOI: 10.1016/j.intimp.2021.107544] [Reference Citation Analysis]
2 Tsai YF, Huang CC, Lin YS, Hsu CY, Huang CP, Liu CY, Chiu JH, Tseng LM. Interleukin 17A promotes cell migration, enhances anoikis resistance, and creates a microenvironment suitable for triple negative breast cancer tumor metastasis. Cancer Immunol Immunother 2021;70:2339-51. [PMID: 33512556 DOI: 10.1007/s00262-021-02867-x] [Reference Citation Analysis]
3 Ramalho R, Rao M, Zhang C, Agrati C, Ippolito G, Wang FS, Zumla A, Maeurer M. Immunometabolism: new insights and lessons from antigen-directed cellular immune responses. Semin Immunopathol 2020;42:279-313. [PMID: 32519148 DOI: 10.1007/s00281-020-00798-w] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
4 Rapoport BL, Steel HC, Theron AJ, Smit T, Anderson R. Role of the Neutrophil in the Pathogenesis of Advanced Cancer and Impaired Responsiveness to Therapy. Molecules 2020;25:E1618. [PMID: 32244751 DOI: 10.3390/molecules25071618] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
5 Caner A, Sadıqova A, Erdoğan A, Namlıses D, Nalbantsoy A, Oltulu F, Toz S, Yiğittürk G, Ozkök E, Gunduz C, Ozbel Y, Haydaroğlu A. Targeting of antitumor ımmune responses with live-attenuated Leishmania strains in breast cancer model. Breast Cancer 2020;27:1082-95. [PMID: 32472473 DOI: 10.1007/s12282-020-01112-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Kui L, Kong Q, Yang X, Pan Y, Xu Z, Wang S, Chen J, Wei K, Zhou X, Yang X, Wu T, Mastan A, Liu Y, Miao J. High-Throughput In Vitro Gene Expression Profile to Screen of Natural Herbals for Breast Cancer Treatment. Front Oncol 2021;11:684351. [PMID: 34490085 DOI: 10.3389/fonc.2021.684351] [Reference Citation Analysis]
7 Filip-psurska B, Zachary H, Strzykalska A, Wietrzyk J. Vitamin D, Th17 Lymphocytes, and Breast Cancer. Cancers 2022;14:3649. [DOI: 10.3390/cancers14153649] [Reference Citation Analysis]
8 Li X, Yu Q, Chen J, Huang H, Liu Z, Wang C, He Y, Zhang X, Li W, Li C, Zhao J, Long W. Prognostic model of invasive ductal carcinoma of the breast based on differentially expressed glycolysis-related genes. PeerJ 2020;8:e10249. [PMID: 33194424 DOI: 10.7717/peerj.10249] [Reference Citation Analysis]
9 Chuang HC, Tan TH. MAP4K3/GLK in autoimmune disease, cancer and aging. J Biomed Sci 2019;26:82. [PMID: 31640697 DOI: 10.1186/s12929-019-0570-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
10 Tzang BS, Chen VC, Hsieh CC, Wang WK, Weng YP, Ho HY, Hsu YT, Hsaio HP, Weng JC, Chen YL. Differential associations of proinflammatory and anti-inflammatory cytokines with depression severity from noncancer status to breast cancer course and subsequent chemotherapy. BMC Cancer 2020;20:686. [PMID: 32703187 DOI: 10.1186/s12885-020-07181-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Lee S, Lim S, Lee T, Sung I, Kim S. Cancer subtype classification and modeling by pathway attention and propagation. Bioinformatics 2020;36:3818-24. [PMID: 32207514 DOI: 10.1093/bioinformatics/btaa203] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
12 Zhukova OV, Arkhipova EV, Kovaleva TF, Ryabov SA, Ivanova IP, Golovacheva AA, Zykova DA, Zaitsev SD. Immunopharmacological Properties of Methacrylic Acid Polymers as Potential Polymeric Carrier Constituents of Anticancer Drugs. Molecules 2021;26:4855. [PMID: 34443443 DOI: 10.3390/molecules26164855] [Reference Citation Analysis]
13 Wang L, Wang W, Zeng S, Zheng H, Lu Q. Construction and validation of a 6-gene nomogram discriminating lung metastasis risk of breast cancer patients. PLoS One 2020;15:e0244693. [PMID: 33378415 DOI: 10.1371/journal.pone.0244693] [Reference Citation Analysis]
14 Yim S, Hwang W, Han N, Lee D. Computational Discovery of Cancer Immunotherapy Targets by Intercellular CRISPR Screens. Front Immunol 2022;13:884561. [PMID: 35651625 DOI: 10.3389/fimmu.2022.884561] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Anderson R, Theron AJ, Rapoport BL. Immunopathogenesis of Immune Checkpoint Inhibitor-Related Adverse Events: Roles of the Intestinal Microbiome and Th17 Cells. Front Immunol 2019;10:2254. [PMID: 31616428 DOI: 10.3389/fimmu.2019.02254] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 6.7] [Reference Citation Analysis]
16 Tang M, Lu L, Yu X. Interleukin-17A Interweaves the Skeletal and Immune Systems. Front Immunol 2020;11:625034. [PMID: 33613566 DOI: 10.3389/fimmu.2020.625034] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 9.0] [Reference Citation Analysis]
17 Lücke J, Shiri AM, Zhang T, Kempski J, Giannou AD, Huber S. Rationalizing heptadecaphobia: TH 17 cells and associated cytokines in cancer and metastasis. FEBS J 2021. [PMID: 33448148 DOI: 10.1111/febs.15711] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Avalos-Navarro G, Muñoz-Valle JF, Daneri-Navarro A, Quintero-Ramos A, Franco-Topete RA, Morán-Mendoza AJ, Oceguera-Villanueva A, Bautista-Herrera LA, Topete-Camacho A, Del Toro-Arreola A. Circulating soluble levels of MIF in women with breast cancer in the molecular subtypes: relationship with Th17 cytokine profile. Clin Exp Med 2019;19:385-91. [PMID: 31102004 DOI: 10.1007/s10238-019-00559-6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
19 Vitiello GA, Miller G. Targeting the interleukin-17 immune axis for cancer immunotherapy. J Exp Med 2020;217:e20190456. [PMID: 31727783 DOI: 10.1084/jem.20190456] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 11.5] [Reference Citation Analysis]
20 Faucheux L, Grandclaudon M, Perrot-Dockès M, Sirven P, Berger F, Hamy AS, Fourchotte V, Vincent-Salomon A, Mechta-Grigoriou F, Reyal F, Scholer-Dahirel A, Guillot-Delost M, Soumelis V. A multivariate Th17 metagene for prognostic stratification in T cell non-inflamed triple negative breast cancer. Oncoimmunology 2019;8:e1624130. [PMID: 31428522 DOI: 10.1080/2162402X.2019.1624130] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
21 Reynaud D, Abi Nahed R, Lemaitre N, Bolze PA, Traboulsi W, Sergent F, Battail C, Filhol O, Sapin V, Boufettal H, Hoffmann P, Aboussaouira T, Murthi P, Slim R, Benharouga M, Alfaidy N. NLRP7 Promotes Choriocarcinoma Growth and Progression through the Establishment of an Immunosuppressive Microenvironment. Cancers (Basel) 2021;13:2999. [PMID: 34203890 DOI: 10.3390/cancers13122999] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
22 Hum NR, Sebastian A, Martin KA, Rios-arce ND, Gilmore SF, Gravano DM, Wheeler EK, Coleman MA, Loots GG. IL-17A Increases Doxorubicin Efficacy in Triple Negative Breast Cancer. Front Oncol 2022;12:928474. [DOI: 10.3389/fonc.2022.928474] [Reference Citation Analysis]
23 Qian XL, Xu P, Zhang YQ, Song YM, Li YQ, Li WD, Jiang CY, Shen BB, Zhang XM, Zhang LN, Fu L, Guo XJ. Increased number of intratumoral IL-17+ cells, a harbinger of the adverse prognosis of triple-negative breast cancer. Breast Cancer Res Treat 2020;180:311-9. [PMID: 31993861 DOI: 10.1007/s10549-020-05540-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
24 Quintero-Fabián S, Arreola R, Becerril-Villanueva E, Torres-Romero JC, Arana-Argáez V, Lara-Riegos J, Ramírez-Camacho MA, Alvarez-Sánchez ME. Role of Matrix Metalloproteinases in Angiogenesis and Cancer. Front Oncol 2019;9:1370. [PMID: 31921634 DOI: 10.3389/fonc.2019.01370] [Cited by in Crossref: 125] [Cited by in F6Publishing: 126] [Article Influence: 41.7] [Reference Citation Analysis]
25 Mostafa AM, Saafan HA, Al-Tawashi AS, Kasem MH, Alaa AM, Eltobgy MM, Moubarak AS, Gharib MM, Awwad MA, Omar HM, El-Derany MO. Interleukin-17 haplotyping predicts hepatocellular carcinoma in sofosbuvir, pegylated interferon-alpha-2a & ribavirin treated chronic hepatitis C patients. Virus Res 2021;292:198226. [PMID: 33171166 DOI: 10.1016/j.virusres.2020.198226] [Reference Citation Analysis]
26 Valenti M, Pavia G, Gargiulo L, Facheris P, Sanna F, Borroni RG, Costanzo A, Narcisi A. Biologic therapies for plaque type psoriasis in patients with previous malignant cancer: long-term safety in a single- center real-life population. J Dermatolog Treat 2021;:1-5. [PMID: 33555951 DOI: 10.1080/09546634.2021.1886231] [Reference Citation Analysis]
27 Ben Khelil M, Godet Y, Abdeljaoued S, Borg C, Adotévi O, Loyon R. Harnessing Antitumor CD4+ T Cells for Cancer Immunotherapy. Cancers (Basel) 2022;14:260. [PMID: 35008422 DOI: 10.3390/cancers14010260] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
28 Mathilakathu A, Borchert S, Wessolly M, Mairinger E, Beckert H, Steinborn J, Hager T, Christoph DC, Kollmeier J, Wohlschlaeger J, Mairinger T, Schmid KW, Walter RFH, Brcic L, Mairinger FD. Mitogen signal-associated pathways, energy metabolism regulation, and mediation of tumor immunogenicity play essential roles in the cellular response of malignant pleural mesotheliomas to platinum-based treatment: a retrospective study. Transl Lung Cancer Res 2021;10:3030-42. [PMID: 34430345 DOI: 10.21037/tlcr-21-201] [Reference Citation Analysis]